Robert Stoehr
Universitätsklinikum Erlangen(DE)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis, Epigenetics and DNA Methylation
Most-Cited Works
- → The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes(2019)231 cited
- → Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern(2007)203 cited
- → Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies(2002)196 cited
- → Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers(2012)189 cited
- → Prediction of Progression of Non–Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study(2008)177 cited
- → Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer(2004)152 cited
- → EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice(2013)151 cited
- → MiR-216a: a link between endothelial dysfunction and autophagy(2014)144 cited
- → Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma)(2015)137 cited
- → Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses(2002)129 cited